NEW YORK (GenomeWeb News) – PerkinElmer and Corning will collaborate to develop label-free detection technologies for the drug discovery market, Corning said today.

Under the agreement, the companies will combine Corning's optical label-free detection technology with PerkinElmer's multi-label detection systems to offer next-generation drug discovery platforms.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.